We are live on
!
Find out more
HCA
Horan Capital Advisors Portfolio holdings
AUM
$297M
1-Year Est. Return
9.75%
This Fund
S&P 500
This Quarter
Est. Return
+3.35%
1 Year Est. Return
+9.75%
3 Year Est. Return
+26.64%
5 Year Est. Return
+133.08%
10 Year Est. Return
+209.33%
AUM
$149M
AUM Growth
-$9.34M
(-5.9%)
Cap. Flow
-$13M
Cap. Flow
% of AUM
-8.72%
Top 10 Holdings %
Top 10 Hldgs %
37.84%
Holding
266
New
2
Increased
9
Reduced
46
Closed
195
Avg Time Held
12.3
quarters
Top 10 Avg Time Held
7.3
quarters
Top 20 Avg Time Held
7.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$2.14M |
| 2 |
Walt Disney
DIS
|
+$852K |
| 3 |
CVS Health
CVS
|
+$808K |
| 4 |
Corteva
CTVA
|
+$452K |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$89.3K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.95M |
| 2 |
Viatris
VTRS
|
+$862K |
| 3 |
DuPont de Nemours
DD
|
+$820K |
| 4 |
Schwab International Equity ETF
SCHF
|
+$357K |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$283K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.73% |
| 2 | Technology | 12.54% |
| 3 | Financials | 12.26% |
| 4 | Communication Services | 12.04% |
| 5 | Healthcare | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
iShares Core S&P Mid-Cap ETF
IJH
$124B
| $13.3M | 8.96% |
342,740
-6,860
| -2% | -$263K |
2013 Q2
24 quarters
|
|
|
2
JPMorgan Ultra-Short Income ETF
JPST
$42.1B
| $10.5M | 7.08% |
208,990
-5,621
| -3% | -$283K |
2018 Q1
5 quarters
|
|
3
Microsoft
MSFT
$3.9T
| $5.47M | 3.68% |
40,868
-1,503
| -4% | -$191K |
2013 Q3
23 quarters
|
|
4
Apple
AAPL
$4.86T
| $5.4M | 3.63% |
109,124
-3,132
| -3% | -$153K |
2018 Q1
5 quarters
|
|
5
JPMorgan Chase
JPM
$884B
| $4.38M | 2.95% |
39,173
-1,216
| -3% | -$134K |
2013 Q2
24 quarters
|
|
6
Alphabet (Google) Class A
GOOGL
$4.24T
| $3.71M | 2.49% |
68,480
-1,740
| -2% | -$101K |
2015 Q4
14 quarters
|
|
7
Verizon
VZ
$190B
| $3.59M | 2.41% |
62,785
-2,138
| -3% | -$123K |
2014 Q1
21 quarters
|
|
8
Comcast
CMCSA
$76.5B
| $3.34M | 2.25% |
79,022
-2,270
| -3% | -$95.8K |
2014 Q3
19 quarters
|
|
9
Thermo Fisher Scientific
TMO
$250B
| $3.31M | 2.22% |
11,262
-453
| -4% | -$125K |
2013 Q2
24 quarters
|
|
10
Home Depot
HD
$281B
| $3.21M | 2.16% |
15,421
-480
| -3% | -$95.7K |
2014 Q2
20 quarters
|
|
11
Procter & Gamble
PG
$339B
| $3.13M | 2.1% |
28,505
-14
| -0% | -$1.49K |
2013 Q2
24 quarters
|
|
12
Trane Technologies
TT
$104B
| $3.08M | 2.08% |
24,357
-1,042
| -4% | -$125K |
2017 Q3
7 quarters
|
|
|
13
Schwab International Equity ETF
SCHF
$68.3B
| $3M | 2.02% |
187,146
-22,566
| -11% | -$357K |
2016 Q4
10 quarters
|
|
14
W.P. Carey
WPC
$14.6B
| $2.95M | 1.98% |
37,102
-1,506
| -4% | -$119K |
2017 Q2
8 quarters
|
|
15
Synchrony
SYF
$23.4B
| $2.88M | 1.94% |
83,012
-4,980
| -6% | -$169K |
2016 Q1
13 quarters
|
|
16
Merck
MRK
$344B
| $2.66M | 1.79% |
33,207
-1,404
| -4% | -$108K |
2018 Q2
4 quarters
|
|
17
Global X MLP ETF
MLPA
$2.29B
| $2.64M | 1.77% |
49,854
-4,057
| -8% | -$214K |
2018 Q4
2 quarters
|
|
18
Cinemark Holdings
CNK
$4.17B
| $2.62M | 1.76% |
72,491
-3,190
| -4% | -$126K |
2013 Q2
24 quarters
|
|
19
Berkshire Hathaway Class B
BRK.B
$1.08T
| $2.6M | 1.75% |
12,175
-246
| -2% | -$50.9K |
2015 Q2
16 quarters
|
|
20
PayPal
PYPL
$46.5B
| $2.58M | 1.74% |
22,578
-945
| -4% | -$105K |
2015 Q3
15 quarters
|
|
21
Intel
INTC
$614B
| $2.56M | 1.72% |
53,405
-255
| -0.5% | -$12.6K |
2013 Q2
24 quarters
|
|
|
22
CVS Health
CVS
$111B
| $2.51M | 1.69% |
45,992
+15,009
| +48% | +$808K |
2013 Q2
24 quarters
|
|
23
Qualcomm
QCOM
$193B
| $2.5M | 1.68% |
32,809
-2,120
| -6% | -$155K |
2013 Q2
24 quarters
|
|
|
RDS.A
24
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.47M | 1.66% |
38,014
-1,920
| -5% | -$123K |
2015 Q3
15 quarters
|
|
25
Walmart Inc
WMT
$834B
| $2.47M | 1.66% |
67,056
-2,571
| -4% | -$88.6K |
2018 Q2
4 quarters
|
|
Similar funds
WGCA
RAM
WFA
PPWP
RI
BCM
IAM
UFA
Horan Capital Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Horan Capital Advisors held 266 positions worth $149M, down 5.9% from $158M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Horan Capital Advisors withdrew a net $13M in Q2 2019, closing 195 positions and reducing 46 holdings. Its most notable exit was Celgene Corp, an estimated $1.95M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 25% a quarter earlier, followed by Technology and Financials.
Against the trend, Horan Capital Advisors opened a new position in Dow Inc worth $2M.
- Horan Capital Advisors's largest Q2 2019 buy was Dow Inc: 40,578 shares worth $2M.
- Horan Capital Advisors added most to Walt Disney in Q2 2019, an estimated $852K increase.
- Horan Capital Advisors's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $820K.
- Horan Capital Advisors fully exited Celgene Corp in Q2 2019, selling an estimated $1.95M.
- Horan Capital Advisors's ten largest holdings make up 38% of its $149M portfolio in Q2 2019.
- Horan Capital Advisors opened 2 new positions and closed 195 in Q2 2019.
- Horan Capital Advisors's portfolio value fell 5.9% quarter-over-quarter to $149M.
Based on Horan Capital Advisors's 13F filing for Q2 2019, filed 26 Jul 2019.